Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-09-005781
Filing Date
2009-02-02
Accepted
2009-02-02 14:09:49
Documents
2
Period of Report
2008-08-21

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 14637
2 POA DOCUMENT poa.txt EX-24.4A_271526 4083
  Complete submission text file 0001209191-09-005781.txt   20645
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1522 217TH PLACE SE SUITE 100 BOTHELL WA 98021
Business Address 425-686-1500
Clendeninn Neil James (Reporting) CIK: 0001442443 (see all company filings)

Type: 4/A | Act: 34 | File No.: 033-80623 | Film No.: 09560948